156 related articles for article (PubMed ID: 19949103)
1. Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases.
Jongerius I; Puister M; Wu J; Ruyken M; van Strijp JA; Rooijakkers SH
J Immunol; 2010 Jan; 184(1):420-5. PubMed ID: 19949103
[TBL] [Abstract][Full Text] [Related]
2. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion.
Laarman AJ; Ruyken M; Malone CL; van Strijp JA; Horswill AR; Rooijakkers SH
J Immunol; 2011 Jun; 186(11):6445-53. PubMed ID: 21502375
[TBL] [Abstract][Full Text] [Related]
4. Identification of a staphylococcal complement inhibitor with broad host specificity in equid
de Jong NWM; Vrieling M; Garcia BL; Koop G; Brettmann M; Aerts PC; Ruyken M; van Strijp JAG; Holmes M; Harrison EM; Geisbrecht BV; Rooijakkers SHM
J Biol Chem; 2018 Mar; 293(12):4468-4477. PubMed ID: 29414776
[No Abstract] [Full Text] [Related]
5. Staphylococcal complement evasion by various convertase-blocking molecules.
Jongerius I; Köhl J; Pandey MK; Ruyken M; van Kessel KP; van Strijp JA; Rooijakkers SH
J Exp Med; 2007 Oct; 204(10):2461-71. PubMed ID: 17893203
[TBL] [Abstract][Full Text] [Related]
6. A human monoclonal antibody that specifically binds and inhibits the staphylococcal complement inhibitor protein SCIN.
Hoekstra H; Romero Pastrana F; Bonarius HPJ; van Kessel KPM; Elsinga GS; Kooi N; Groen H; van Dijl JM; Buist G
Virulence; 2018 Jan; 9(1):70-82. PubMed ID: 28277903
[TBL] [Abstract][Full Text] [Related]
7. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus.
Rooijakkers SH; Ruyken M; van Roon J; van Kessel KP; van Strijp JA; van Wamel WJ
Cell Microbiol; 2006 Aug; 8(8):1282-93. PubMed ID: 16882032
[TBL] [Abstract][Full Text] [Related]
8. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
[TBL] [Abstract][Full Text] [Related]
9. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
10. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
[TBL] [Abstract][Full Text] [Related]
11. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
12. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.
van Wamel WJ; Rooijakkers SH; Ruyken M; van Kessel KP; van Strijp JA
J Bacteriol; 2006 Feb; 188(4):1310-5. PubMed ID: 16452413
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
[TBL] [Abstract][Full Text] [Related]
14. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
[TBL] [Abstract][Full Text] [Related]
15. Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.
Jongerius I; Garcia BL; Geisbrecht BV; van Strijp JAG; Rooijakkers SHM
J Biol Chem; 2010 May; 285(20):14973-14979. PubMed ID: 20304920
[TBL] [Abstract][Full Text] [Related]
16. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
[TBL] [Abstract][Full Text] [Related]
17. The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase.
Woehl JL; Stapels DAC; Garcia BL; Ramyar KX; Keightley A; Ruyken M; Syriga M; Sfyroera G; Weber AB; Zolkiewski M; Ricklin D; Lambris JD; Rooijakkers SHM; Geisbrecht BV
J Immunol; 2014 Dec; 193(12):6161-6171. PubMed ID: 25381436
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b.
Garcia BL; Ramyar KX; Tzekou A; Ricklin D; McWhorter WJ; Lambris JD; Geisbrecht BV
J Mol Biol; 2010 Sep; 402(1):17-29. PubMed ID: 20654625
[TBL] [Abstract][Full Text] [Related]
19. Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family.
Garcia BL; Summers BJ; Lin Z; Ramyar KX; Ricklin D; Kamath DV; Fu ZQ; Lambris JD; Geisbrecht BV
J Biol Chem; 2012 Jan; 287(1):628-640. PubMed ID: 22086928
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.
Hair PS; Echague CG; Rohn RD; Krishna NK; Nyalwidhe JO; Cunnion KM
J Transl Med; 2012 Mar; 10():35. PubMed ID: 22390383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
